These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3930113)
1. Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. Hafler DA; Hemler ME; Christenson L; Williams JM; Shapiro HM; Strom TB; Strominger JL; Weiner HL Clin Immunol Immunopathol; 1985 Nov; 37(2):163-71. PubMed ID: 3930113 [TBL] [Abstract][Full Text] [Related]
2. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Hafler DA; Fox DA; Manning ME; Schlossman SF; Reinherz EL; Weiner HL N Engl J Med; 1985 May; 312(22):1405-11. PubMed ID: 2985995 [TBL] [Abstract][Full Text] [Related]
3. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes. Bellamy AS; Calder VL; Feldmann M; Davison AN Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109 [TBL] [Abstract][Full Text] [Related]
4. IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Tournier-Lasserve E; Lyoncaen O; Roullet E; Bach MA Clin Exp Immunol; 1987 Mar; 67(3):581-6. PubMed ID: 3038441 [TBL] [Abstract][Full Text] [Related]
5. Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients. DeFreitas EC; Sandberg-Wollheim M; Schonely K; Boufal M; Koprowski H Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2637-41. PubMed ID: 3085102 [TBL] [Abstract][Full Text] [Related]
6. Determination of activated lymphocytes in peripheral blood of patients with multiple sclerosis. Crockard AD; McNeill TA; McKirgan J; Hawkins SA J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):139-41. PubMed ID: 2965217 [TBL] [Abstract][Full Text] [Related]
7. Activated T lymphocytes in uveitis. Deschênes J; Char DH; Kaleta S Br J Ophthalmol; 1988 Feb; 72(2):83-7. PubMed ID: 2964862 [TBL] [Abstract][Full Text] [Related]
8. Differentiation and activation phenotypes of lung T lymphocytes differ from those of circulating T lymphocytes. Davidson BL; Faust J; Pessano S; Daniele RP; Rovera G J Clin Invest; 1985 Jul; 76(1):60-5. PubMed ID: 3926821 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Rudick RA; Carpenter CS; Cookfair DL; Tuohy VK; Ransohoff RM Neurology; 1993 Oct; 43(10):2080-7. PubMed ID: 8105424 [TBL] [Abstract][Full Text] [Related]
10. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Pallone F; Fais S; Squarcia O; Biancone L; Pozzilli P; Boirivant M Gut; 1987 Jun; 28(6):745-53. PubMed ID: 3040543 [TBL] [Abstract][Full Text] [Related]
11. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation. Redelman D Cytometry; 1987 Mar; 8(2):170-83. PubMed ID: 3107949 [TBL] [Abstract][Full Text] [Related]
13. The failure of monoclonal antibody-defined lymphocyte subsets to monitor disease activity in patients with multiple sclerosis. Rice GP; Sipe JC; Braheny SL; Knobler RL; Finney DA; Oldstone MB Ann N Y Acad Sci; 1984; 436():271-80. PubMed ID: 6241819 [No Abstract] [Full Text] [Related]
14. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. Cotner T; Williams JM; Christenson L; Shapiro HM; Strom TB; Strominger J J Exp Med; 1983 Feb; 157(2):461-72. PubMed ID: 6296263 [TBL] [Abstract][Full Text] [Related]
15. Activated T lymphocytes in patients with multiple sclerosis in clinical remission. Konttinen YT; Bergroth V; Kinnunen E; Nordström D; Kouri T J Neurol Sci; 1987 Nov; 81(2-3):133-9. PubMed ID: 3121798 [TBL] [Abstract][Full Text] [Related]
16. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases]. Tournier-Lasserve E; Lyon-Caen O; Roullet E; Bach MA Pathol Biol (Paris); 1987 Mar; 35(3):303-6. PubMed ID: 3108835 [TBL] [Abstract][Full Text] [Related]
17. Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients. Calder VL; Bellamy AS; Owen S; Lewis C; Rudge P; Davison AN; Feldmann M Clin Exp Immunol; 1987 Dec; 70(3):570-7. PubMed ID: 3124996 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. Hofman FM; von Hanwehr RI; Dinarello CA; Mizel SB; Hinton D; Merrill JE J Immunol; 1986 May; 136(9):3239-45. PubMed ID: 3082983 [TBL] [Abstract][Full Text] [Related]
19. [Expression of Fas-antigen on T cells in multiple sclerosis]. Tanaka H; Ota K; Ikusaka M; Ejima M; Maruyama S Rinsho Shinkeigaku; 1995 Mar; 35(3):299-301. PubMed ID: 7542188 [TBL] [Abstract][Full Text] [Related]
20. Correlation between the phenotype and the functional capacity of activated T cells in patients with active systemic lupus erythematosus. Volk HD; Kopp J; Körner IJ; Jahn S; Grunow R; Barthelmes H; Fiebig H Scand J Immunol; 1986 Jul; 24(1):109-14. PubMed ID: 3014641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]